# Prelude Therapeutics Inc: Form 8-K, filed Jun 13, 2025

- Company: [Prelude Therapeutics Inc](/companies/prld.md) (CIK 1678660)
- Form: 8-K
- Filed: 2025-06-13
- Accepted by EDGAR: Jun 13, 2025, 16:10 ET
- Period: 2025-06-11
- Accession: 0000950170-25-086170
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1678660/000095017025086170/prld-20250611.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1678660/000095017025086170/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1678660/000095017025086170/prld-20250611.htm

Filed Jun 13, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-086170. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.